Skip to main content

ERRATUM article

Front. Allergy, 03 April 2023
Sec. Drug, Venom & Anaphylaxis
Volume 4 - 2023 | https://doi.org/10.3389/falgy.2023.1183702

Erratum: Intradermal testing with COVID-19 mRNA vaccines predicts tolerance

This article is an erratum on:

  1. Intradermal Testing With COVID-19 mRNA Vaccines Predicts Tolerance

    1. Read original article
\r\nFrontiers Production Office \r\nFrontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on

Intradermal testing with COVID-19 mRNA vaccines predicts tolerance

By Stehlin F, Mahdi-Aljedani R, Canton L, Monzambani-Banderet V, Miauton A, Girard C, Kammermann K, Meylan S, Ribi C, Harr T, Yerly D and Muller YD. (2022) Front. Allergy 3:818049. doi: 10.3389/falgy.2022.818049

An omission to the Funding section of the original article was made in error. The following sentence has been added: “Open access funding provided by University of Lausanne”.

The original version of this article has been updated.

Keywords: SARS-CoV-2, allergy, vaccine, polyethylene glycol, PEG, COVID-19, anaphylaxis, basophil activation test

Citation: Frontiers Production Office (2023) Erratum: Intradermal testing with COVID-19 mRNA vaccines predicts tolerance. Front. Allergy 4:1183702. doi: 10.3389/falgy.2023.1183702

Received: 10 March 2023; Accepted: 10 March 2023;
Published: 3 April 2023.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

© 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn

Specialty Section: This article was submitted to Drug, Venom & Anaphylaxis, a section of the journal Frontiers in Allergy

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.